The Pathogenetic Dilemma of Post-COVID-19 Mucormycosis in India

There has been a surge of mucormycosis cases in India in the wake of the second wave of COVID-19 with more than 40000 cases reported. Mucormycosis in patients of COVID-19 in India is at variance to other countries where Aspergillus, Pneumocystis, and Candida have been reported to be the major second...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakrabarti, Sankha Shubhra, Kaur, Upinder, Aggarwal, Sushil Kumar, Kanakan, Ahalya, Saini, Adesh, Agrawal, Bimal Kumar, Jin, Kunlin, Chakrabarti, Sasanka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JKL International LLC 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782544/
https://www.ncbi.nlm.nih.gov/pubmed/35111359
http://dx.doi.org/10.14336/AD.2021.0811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782544/
https://www.ncbi.nlm.nih.gov/pubmed/35111359
http://dx.doi.org/10.14336/AD.2021.0811

Ejemplares similares